生血宝合剂联合右旋糖酐铁片治疗妊娠期缺铁性贫血的有效性及安全性分析①
彭 茜
(宜春市妇幼保健院妇产科,江西 宜春 336000)
摘要 目的:分析妊娠期缺铁性贫血(IDA)治疗中,以生血宝合剂联合右旋糖酐铁片的干预效果。方法:将 80 例 IDA 患者作为研究对象,随机分为对照组与观察组。 对照组给予单药右旋糖酐铁片,观察组在对照组基础上联合生血宝合剂治疗。 以治疗效果、安全性为评估标准。 结果:观察组治疗有效率高于对照组,患者机体贫血相关评估治疗后均优于对照组,患者用药安全性高于对照组,不良妊娠结局发生率低于对照组,以上差异均具有统计学意义(P<0.05)。 结论:生血宝合剂联合右旋糖酐铁片治疗 IDA 患者,可提升贫血改善效果,促使相关贫血指标改善,可获得较好的预后。
关键词: IDA;右旋糖酐铁片;生血宝合剂;联合治疗
中图分类号:R714 文献标志码:A 文章编号:1008-2409(2022)03-0057-04
Efficacy and safety of Shengxuebaoheji combined with iron dextran tablet in the treatment of pregnant women with iron deficiency anemia during pregnancy ①
PENG Qian. (Dept. of Obstetrics & Gynecology, Yichun Maternal and child Health Hospital,Yichun 336000, China)
Abstract Objective: To analyze the intervention effect of Shengxuebaoheji combined with iron dextran tablets in the treatment of pregnant women with iron deficiency anemia(IDA)during pregnancy. Methods: 80 patients with IDA included in the clinical study were randomized into the control group and observation group. The control group were administered with iron dextran tablet only, while the observation group received Shengxuebaoheji therapy on the basis of the treatment for the control group. And the therapeutic effect and safety were used as the evaluation criteria. Results: The effective rate of the observation group was higher than that of the control group, the related evaluation of anemia was better than that of the control group after treatment, the safety of drug use for the patients was higher than that of the control group, and the incidence of adverse pregnancy outcomes was lower than that of the control group(P<0.05).Conclusion: The application of Shengxuebaoheji to IDA patients treated with iron dextran tablets can improve the effect of anemia, promote the improvement of relevant anemia indexes and obtain a better prognosis.
Keywords: IDA; iron dextran tablets; Shengxuebaoheji; combined therapy
参考文献:
[1] 柯桂花,张红,唐丽芳.生血宝合剂联合右旋糖酐铁分散片治疗妊娠期孕妇缺铁性贫血的临床研究[J].黑龙江医学,2020,44(5):629-631.
[2] 刘侃,武海英,王秋明.产后贫血采用生血宝合剂治疗的临床效果研究[J].世界临床医学,2019,13(1):76-77.
[3] 王琳,涂杰霞,尹曦,等.2 种铁剂治疗妊娠期合并缺铁性贫血的成本-效果分析[J].中国医院药学杂志,2019,39(9):982-985.
[4] 左彩霞.生血宝合剂联合生血宁片治疗妊娠期缺铁性贫血效果观察[J].临床合理用药杂志,2020,13(8):80-81.
[5] 吴进,李慧,肖凯,等.右旋糖酐铁联合 EPO 治疗妊娠期缺铁性贫血疗效及其对 RET,Hepcidin-25 水平的影响[J].疑难病杂志,2021,20(5):492-496.
[6] 曹远芳,崔文婷,欧阳鹏.生血宝合剂联合蔗糖铁治疗肝肾阴虚型缺铁性贫血的效果研究[J].基层医学论坛,2019,23(20):2868-2869.
[7] 周振昭,吴立明,陈宇.补中益气颗粒联合多糖铁复合物治疗妊娠期缺铁性贫血疗效和安全性分析[J].国际生殖健康/ 计划生育杂志,2019,38(2):116-119.
[8] 陈小妹,刘勇.生血宝合剂联合 rhu-EPO 治疗肿瘤化疗相关性贫血的疗效观察[J].中国医学创新,2019,16(30):65-69.
[9] 邓玲玲,李洁.口服铁剂联合生血宝对妊娠期贫血孕妇贫血状态及母婴结局的影响[J]. 中国医药指南,2020,18(20):95-96.
[10] 孙曼,周莉,廖平英.健脾生血片治疗妊娠期缺铁性贫血的效果[J].中国当代医药,2020,27(14):121-123.
PDF下载：点击下载
版权所有：华夏医学(Acta Medicinae Sinica) 联系电话：0773-2805467 电子邮箱：huaxia@glmc.edu.cn 地址：广西桂林市临桂区致远路1号桂林医学院明德楼316 (541199)